Jean‐Philippe ChippauxAlejandra N. Salas ClavijoJosé SantallaJorge R. PostigoDominik T. SchneiderLaurent Brutus2026-03-222026-03-22200910.1111/j.1365-3156.2009.02431.xhttps://doi.org/10.1111/j.1365-3156.2009.02431.xhttps://andeanlibrary.org/handle/123456789/44822Citaciones: 42Recovery may be confirmed in most cases at 10 months. The CSP test was compared to Chagatest v3.0 ELISA and appeared to give a reliable response. The decrease rate of antibodies does not depend on treatment modes.enBenznidazoleTrypanosoma cruziSerologyChagas diseaseAntibodyMedicineParasitemiaVirologyImmunologyAntibody drop in newborns congenitally infected by<i>Trypanosoma cruzi</i>treated with benznidazolearticle